Needham Maintains Buy on Cardlytics, Lowers Price Target to $12
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Kyle Peterson has maintained a 'Buy' rating on Cardlytics (NASDAQ:CDLX), but lowered the price target from $19 to $12.
November 09, 2023 | 1:27 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Needham analyst has maintained a 'Buy' rating on Cardlytics but lowered the price target from $19 to $12.
The news is directly related to Cardlytics (CDLX). While the 'Buy' rating is maintained, the lowering of the price target from $19 to $12 might create a mixed sentiment among investors. This could potentially lead to short-term volatility in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100